HONORINE NJITA: Open Payments
NPI 1124322672 · HIGHLAND PARK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 40 payments from 16 companies in 2025. Trend: 2023 $253 · 2024 $0 · 2025 $1,015
Food & beverage: $903Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $339 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $57 |
| Lundbeck LLC | 3 | $56 |
| Alkermes, Inc. | 2 | $56 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| ABBVIE INC. | 3 | $50 |
| Luye Pharma (USA) Ltd. | 2 | $35 |
Products named: UZEDY, REXULTI, INGREZZA, FANAPT, ABILIFY ASIMTUFII, INVEGA SUSTENNA, ARISTADA, Auvelity.
Industry payments across MI — which companies pay providers there.
